Prime Islami Life Insurance Limited (DSE:PRIMELIFE)
Bangladesh · Delayed Price · Currency is BDT 42.40
-1.40 (-3.20%)
At close: Jun 15, 2026
DSE:PRIMELIFE Income Statement
Financials in millions BDT. Fiscal year is January - December.
Millions BDT. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Premiums & Annuity Revenue | 3,794 | 4,036 | 4,130 | 4,273 | 4,120 |
Total Interest & Dividend Income | 48.57 | 82.75 | 111.77 | 132.06 | -21.74 |
Gain (Loss) on Sale of Investments | - | - | -1.3 | -5.15 | - |
Other Revenue | 2.02 | 5.03 | 2.18 | 5.68 | 3.47 |
| 3,845 | 4,124 | 4,242 | 4,406 | 4,102 | |
Revenue Growth (YoY) | -6.78% | -2.79% | -3.71% | 7.40% | 9.63% |
Policy Benefits | 2,808 | 2,932 | 2,996 | 2,946 | 2,813 |
Policy Acquisition & Underwriting Costs | 425.7 | 501.95 | 576.48 | 623.03 | 592.62 |
Depreciation & Amortization | 19.23 | 20.06 | 22.63 | 24.38 | 17.81 |
Selling, General & Administrative | 234.33 | 274.81 | 352.19 | 380.45 | 385.97 |
Provision for Bad Debts | 51.61 | 51.94 | 0.5 | 1.35 | 1.34 |
Other Operating Expenses | 5.51 | 6.93 | 10.81 | 19.65 | 7.94 |
Total Operating Expenses | 3,989 | 4,282 | 4,474 | 4,541 | 4,420 |
Operating Income | -144.85 | -158.38 | -231.67 | -134.77 | -318.22 |
Interest Expense | -7.23 | -9.41 | -19.96 | -17.71 | -14.03 |
Other Non Operating Income (Expenses) | -10.09 | -12.27 | -14.79 | -16.48 | -14.3 |
EBT Excluding Unusual Items | -162.18 | -180.06 | -266.41 | -168.96 | -346.55 |
Gain (Loss) on Sale of Assets | - | 0.13 | - | - | - |
Asset Writedown | - | -2.84 | -43.07 | -7.34 | - |
Other Unusual Items | - | -0.6 | -1.25 | - | -15 |
Pretax Income | -162.18 | -183.37 | -310.73 | -176.3 | -361.55 |
Income Tax Expense | 2.55 | 2.53 | 53.3 | 83.64 | 128.92 |
Earnings From Continuing Ops. | -164.73 | -185.9 | -364.03 | -259.94 | -490.47 |
Minority Interest in Earnings | 29.68 | 13.71 | 6.69 | -10.59 | 35.43 |
Net Income | -135.04 | -172.19 | -357.34 | -270.53 | -455.04 |
Net Income to Common | -135.04 | -172.19 | -357.34 | -270.53 | -455.04 |
Shares Outstanding (Basic) | 31 | 31 | 31 | 31 | 31 |
Shares Outstanding (Diluted) | 31 | 31 | 31 | 31 | 31 |
EPS (Basic) | -4.42 | -5.64 | -11.71 | -8.86 | -14.91 |
EPS (Diluted) | -4.42 | -5.64 | -11.71 | -8.86 | -14.91 |
Free Cash Flow | 62.69 | 93.76 | -122.82 | -120.98 | -77.42 |
Free Cash Flow Per Share | 2.05 | 3.07 | -4.02 | -3.96 | -2.54 |
Dividend Per Share | - | 0.100 | 0.200 | - | - |
Dividend Growth | - | -50.00% | - | - | - |
Operating Margin | -3.77% | -3.84% | -5.46% | -3.06% | -7.76% |
Profit Margin | -3.51% | -4.17% | -8.42% | -6.14% | -11.09% |
Free Cash Flow Margin | 1.63% | 2.27% | -2.90% | -2.75% | -1.89% |
EBITDA | -132.44 | -145.13 | -215.85 | -117.2 | -300.41 |
EBITDA Margin | -3.45% | -3.52% | -5.09% | -2.66% | -7.32% |
D&A For EBITDA | 12.41 | 13.25 | 15.82 | 17.57 | 17.81 |
EBIT | -144.85 | -158.38 | -231.67 | -134.77 | -318.22 |
EBIT Margin | -3.77% | -3.84% | -5.46% | -3.06% | -7.76% |